The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury

British Journal of Pharmacology

Volumn 132, Issue 7, 2001, Pages 1615-1623

  Suzuki, Rie ^a   Stanfa, Louise C ^a   Kowaluk, Elizabeth A ^b   Williams, Michael ^b   Jarvis, Michael F ^b   Dickenson, Anthony H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Adenosine; Adenosine kinase inhibitor; Carrageenan inflammation; Electrophysiology; Neuropathic pain; Spinal nerve ligation

Indexed keywords

4 AMINO 4 (3 BROMOPHENYL) 7 (6 MORPHOLINOPYRIDIN 3 YL) PYRIDO[2,3 D]PYRIMIDINE; ABT 702; ADENOSINE KINASE INHIBITOR; CARRAGEENAN; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ELECTROPHYSIOLOGY; EVOKED RESPONSE; INFLAMMATION; MALE; NERVE INJURY; NERVE LIGATION; NOCICEPTION; NONHUMAN; PAIN; PLASTICITY; PRIORITY JOURNAL; RAT; SPINAL CORD NERVE CELL;

EID: 0035066663     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703972     Document Type: Article

References (39)

1. Activities and some properties of 5′-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of the concentration and the physiological role of adenosine
2. The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain
3. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain
4. Site and event specific increase of striatal adenosine release by adenosine kinase inhibition in rats
5. Adenosine as a potential analgesic target in inflammatory and neuropathic pains
6. Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors
7. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices
8. ABT-702, A novel orally effective adenosine kinase inhibitor analgesic with anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse
9. An Al-selective adenosine agonist abolishes allodynia elicited by vibration and touch after intrathecal injection
10. Effects of intrathecal injection of the adenosine receptor agonists R-phenylisopropyl-adenosine and N-ethylcarboxamide-adenosine on nociception and motor function in the rat
11. Local antinociceptive and hyperalgesic effects in the formalin test after peripheral administration of adenosine analogues in mice
12. Local and remote modifications of nociceptive sensitivity during carrageenan-induced inflammation in the rat
13. Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor
14. Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice
15. Altered sensory behaviors in mice following manipulation of endogenous spinal adenosine neurotransmission
16. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat
17. Characterization of the effects of adenosine kinase inhibitors in acute thermal nociception in mice
18. ABT-702. A novel orally effective adenosine kinase inhibitor analgesic with anti-inflammatory properties: II. In vivo characterization in the rat
19. Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain
20. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists
21. An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain
22. Turnover of adenosine in plasma of human and dog blood
23. Antinociception by adenosine analogs and an adenosine kinase inhibitor: Dependence on formalin concentration
24. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat
25. Antinociceptive and anti-inflammatory properties of an adenosine kinase inhibitor and an adenosine deaminase inhibitor
26. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy
27. The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat
28. Adenosine receptor activation and nociception
29. Purines in pain management
30. The role of purines in nociception
31. Classification of adenosine receptors mediating antinociception in the rat spinal cord
32. Intrathecal administration of the adenosine A1 receptor agonist R-phenylisopropyl adenosine reduces presumed pain behaviour in a rat model of central pain
33. Systemic adenosine infusion: A new treatment modality to alleviate neuropathic pain
34. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenan inflammation
35. The inhibitory effects of the A1 adenosine receptor agonist, N6-cyclopentyladenosine on the electrical and natural evoked responses of spinal dorsal horn neurones in a rat model of mononeuropathy
36. Comparison of the effects of MK-801, ketamine and memantine on responses of spinal dorsal horn neurones in a rat model of mononeuropathy
37. Intrathecal adenosine does not relieve allodynia-like behaviour in spinally injured rats
38. Reduced anti-allodynic effect of the adenosine A1-receptor agonist R-phenylisopropyladenosine on repeated intrathecal administration and lack of cross-tolerance with morphine in a rat model of central pain
39. Ethical guidelines for investigations of experimental pain in conscious animals